false
0001267813
0001267813
2024-05-22
2024-05-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): May 22, 2024
Marinus
Pharmaceuticals, Inc.
(Exact name of registrant as specified
in its charter)
Delaware |
001-36576 |
20-0198082 |
(State or other jurisdiction of
incorporation) |
(Commission File Number) |
(IRS Employer Identification
No.) |
5 Radnor Corporate Center, Suite 500
100
Matsonford Rd, Radnor, PA |
19087 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s
telephone number, including area code: (484) 801-4670
__________________________________________________________________
(Former name or former address,
if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $0.001 |
MRNS |
Nasdaq Global Market |
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02. Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As
described in Item 5.07 below, on May 22, 2024, Marinus Pharmaceuticals, Inc. (the “Company”) held its 2024 Annual Meeting
of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the Marinus Pharmaceuticals,
Inc. 2024 Equity Incentive Plan (the “2024 Plan”).The number of shares of
common stock issuable under the 2024 Plan is 4,000,000 shares, plus shares that become available for grant under the Company’s 2014
Equity Incentive Plan, as amended (the “2014 Plan”), after May 22, 2024 (the date in which the Company’s stockholders
approved the 2024 Plan) as a result of the termination or forfeiture of awards under the 2014 Plan.
A
summary of the 2024 Plan is set forth in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission
on April 4, 2024 (the “Proxy Statement”). Such summary and the above description of the 2024 Plan do not purport to be complete
and are qualified in their entirety by reference to the 2024 Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and
is incorporated herein by reference.
Item
5.07. Submission of Matters to a Vote of Security Holders.
On
May 22, 2024, the Company held the Annual Meeting. Of the 54,931,042 shares of common stock outstanding and entitled to vote at the Annual Meeting, 50,185,167 shares, or
91.4% were present, either by remote communication or represented by proxy, constituting a quorum. The following provides a summary of
the votes cast for the proposals on which the Company’s stockholders voted at the Annual Meeting:
Proposal
1: Election of three Class I directors to the Company’s Board of Directors, each to serve until the Company’s
2027 Annual Meeting of Stockholders or until such person’s successor is duly elected and qualified.
The Company’s stockholders
elected each of the following individuals to serve as Class I directors to serve until the Company’s 2027 Annual Meeting of Stockholders
or until such individual’s successor is duly elected and qualified, and the results of the vote were as follows:
Director Nominee | |
Votes For | |
Votes Withheld | |
Broker Non-Votes |
Elan Ezickson | |
33,666,008 | |
10,969,840 | |
5,549,319 |
Charles Austin | |
39,874,244 | |
4,761,604 | |
5,549,319 |
Marvin H Johnson, Jr. | |
39,924,208 | |
4,711,640 | |
5,549,319 |
Proposal
2: Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2024.
The Company’s stockholders
approved Proposal 2. The results of the vote were as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
50,133,065 |
|
42,477 |
|
9,625 |
|
- |
Proposal
3: Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers as disclosed
in the Proxy Statement.
The Company’s stockholders
approved Proposal 3. The results of the vote were as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
34,529,488 |
|
9,940,832 |
|
165,528 |
|
5,549,319 |
Proposal
4: Approval of the 2024 Plan.
The Company's stockholders approved Proposal 4. The results of the vote were as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
32,505,734 |
|
11,953,605 |
|
176,509 |
|
5,549,319 |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
MARINUS PHARMACEUTICALS, INC. |
|
|
Date: May 24, 2024 |
/s/ Steven Pfanstiel |
|
Steven Pfanstiel |
|
Chief Operating Officer, Chief Financial Officer and Treasurer |
Exhibit 10.1
MARINUS PHARMACEUTICALS, INC.
2024 EQUITY INCENTIVE PLAN
The Plan is intended to (a) provide
eligible persons with an incentive to contribute to the success of the Company and to operate and manage the Company’s business
in a manner that will provide for the Company’s long-term growth and profitability to benefit its stockholders and other important
stakeholders, including its employees and customers, and (b) provide a means of obtaining, rewarding and retaining key personnel.
To this end, the Plan provides for the grant of awards of stock options, stock appreciation rights, restricted stock, restricted stock
units, deferred stock units, unrestricted stock, dividend equivalent rights, performance shares and other performance-based awards, and
other equity-based awards. Any of these awards may, but need not, be made as performance incentives to reward the holders of such awards
for the achievement of performance goals in accordance with the terms of the Plan. Stock options granted under the Plan may be nonqualified
stock options or incentive stock options, as provided in the Plan.
For purposes of interpreting
the Plan documents (including the Plan and Award Agreements), the following definitions will apply:
2.1 “Affiliate”
means any company or other entity that controls, is controlled by or is under common control with the Company within the meaning of
Rule 405 of Regulation C under the Securities Act, including any Subsidiary.
2.2 “Applicable
Laws” means the legal requirements relating to the Plan and the Awards under (a) applicable provisions of the corporate,
securities, tax and other laws, rules, regulations and government orders of any jurisdiction applicable to Awards granted to residents
therein and (b) the rules of any Stock Exchange on which the Common Stock is listed.
2.3 “Award”
means a grant under the Plan of an Option, a Stock Appreciation Right, Restricted Stock, a Restricted Stock Unit, a Deferred Stock Unit,
Unrestricted Stock, a Dividend Equivalent Right, a Performance Share or other Performance-Based Award, or an Other Equity-Based Award.
2.4 “Award
Agreement” means the written agreement between the Company and a Grantee that evidences and sets out the terms and conditions
of an Award.
2.5 “Award
Shares” will have the meaning set forth in Section 17.3(a)(ii).
2.6 “Benefit
Arrangement” will have the meaning set forth in Section 15.
2.7 “Board”
means the Board of Directors of the Company.
2.8 “Cause”
means, with respect to any Grantee, as determined by the Committee and unless otherwise provided in an applicable agreement between
such Grantee and the Company or an Affiliate, that the Grantee (a) has breached his or her employment or service contract with the
Company or an Affiliate in any material respect, (b) has engaged in disloyalty to the Company, including, without limitation, fraud,
embezzlement, theft, commission of a felony or proven dishonesty, (c) has disclosed trade secrets or confidential information of
the Company or an Affiliate to persons not entitled to receive such information, (d) has breached any written noncompetition or nonsolicitation
agreement between the Grantee and the Company or an Affiliate or (e) has engaged in such other behavior detrimental to the interests
of the Company or an Affiliate as the Committee determines. Any determination by the Committee whether an event constituting Cause has
occurred will be final, binding and conclusive.
2.9 “Change
in Control” means, with respect to an Award, unless otherwise provided in the Award Agreement between such Grantee and the Company
or an Affiliate, the occurrence, in a single transaction or in a series of related transaction, of any of the following:
(a) Any
“person,” as such term is used in Sections 13(d) and 14(d) of the Exchange Act becomes a “beneficial owner”
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50%
of the voting power of the then outstanding securities of the Company; provided that a Change in Control shall not be deemed to occur
as a result of (i) a transaction in which the Company becomes a subsidiary of another corporation and in which the stockholders of
the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares entitling such stockholders
to more than 50% of all votes to which all stockholders of the parent corporation would be entitled in the election of directors, or (ii) the
acquisition of securities of the Company by an investor of the Company in a capital-raising transaction; or
(b) The
consummation of (i) a merger or consolidation of the Company with another corporation where the stockholders of the Company, immediately
prior to the merger or consolidation, will not beneficially own, immediately after the merger or consolidation, shares entitling such
stockholders to more than 50% of all votes to which all stockholders of the surviving corporation would be entitled in the election of
directors, (ii) a sale or other disposition of all or substantially all of the assets of the Company, or (iii) a liquidation
or dissolution of the Company.
The Committee shall have
full and final authority, in its sole discretion, to determine conclusively whether a Change in Control has occurred pursuant to the above
definition, the date of the occurrence of such Change in Control, and any incidental matters relating thereto.
2.10 “Code”
means the Internal Revenue Code of 1986, as amended, as now in effect or as hereafter amended, and any successor thereto. References in
the Plan to any Code Section will be deemed to include, as applicable, regulations promulgated under such Code Section.
2.11 “Committee”
means a committee of, and designated from time to time by resolution of, the Board, which will be constituted as provided in Section 3.1(b) and
Section 3.1(c) (or, if no Committee has been so designated, the Board).
2.12 “Common
Stock” means the common stock of the Company, par value $0.001 per share, or any security that shares of Common Stock may be
changed into or for which shares of Common Stock may be exchanged as provided in Section 17.1.
2.13 “Company”
means Marinus Pharmaceuticals, Inc., a Delaware corporation.
2.14 “Deferred
Stock Unit” means a Restricted Stock Unit, the terms of which provide for delivery of the underlying shares of Common Stock
subsequent to the date of vesting, at a time or times consistent with the requirements of Code Section 409A.
2.15 “Determination
Date” means the Grant Date or such other date as of which the Fair Market Value of a share of Common Stock is required to be
established for purposes of the Plan.
2.16 “Disability”
means the inability of a Grantee to perform each of the essential duties of such Grantee’s position by reason of a medically
determinable physical or mental impairment that is potentially permanent in character or that can be expected to last for a continuous
period of not less than 12 months; provided that, with respect to rules regarding expiration of an Incentive Stock Option
following termination of a Grantee’s Service, Disability will mean the inability of such Grantee to engage in any substantial gainful
activity by reason of a medically determinable physical or mental impairment that can be expected to result in death or that has lasted
or can be expected to last for a continuous period of not less than 12 months.
2.17 “Dividend
Equivalent Right” means a right, granted to a Grantee pursuant to Section 13, to receive cash, Common Stock, other
Awards or other property equal in value to dividends or other periodic payments paid or made with respect to a specified number of shares
of Common Stock.
2.18 “Effective
Date” means the date the of Company’s stockholders approval of the Plan, the Plan having been adopted by the Board on
March 26, 2024.
2.19 “Employee”
means, as of any date of determination, an employee (including an officer) of the Company or an Affiliate.
2.20 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, as now in effect or as hereafter amended.
2.21 “Fair
Market Value” means the fair market value of a share of Common Stock for purposes of the Plan, which will be determined as of
any Determination Date as follows:
(a) If
on such Determination Date the shares of Common Stock are listed on a Stock Exchange, or is publicly traded on another established securities
market (a “Securities Market”), the Fair Market Value of a share of Common Stock will be the closing price of the Common
Stock on such Determination Date as reported on such Stock Exchange or such Securities Market (provided that, if there is more
than one such Stock Exchange or Securities Market, the Committee will designate the appropriate Stock Exchange or Securities Market for
purposes of the Fair Market Value determination). If there is no such reported closing price on such Determination Date, the Fair Market
Value of a share of Common Stock will be the closing price of the Common Stock on the immediately preceding day on which any sale of Common
Stock will have been reported on such Stock Exchange or such Securities Market.
(b) If
on such Determination Date the shares of Common Stock are not listed on a Stock Exchange or publicly traded on a Securities Market, the
Fair Market Value of a share of Common Stock will be the value of the Common Stock on such Determination Date as determined by the Committee
by the reasonable application of a reasonable valuation method, in a manner consistent with Code Section 409A.
Notwithstanding this Section 2.21
or Section 18.3, for purposes of determining taxable income and the amount of the related tax withholding obligation pursuant
to Section 18.3, the Fair Market Value shall be determined by the Committee in good faith using any reasonable method it deems
appropriate, to be applied consistently with respect to Grantees; provided that the Committee shall determine the Fair Market Value of
shares of Common Stock for tax withholding obligations due in connection with sales, by or on behalf of a Grantee, of such shares of Common
Stock subject to an Award to pay the Option Price, SAR Price, and/or any tax withholding obligation on the same date on which such shares
may first be sold pursuant to the terms of the applicable Award Agreement (including broker-assisted cashless exercises of Options and
Stock Appreciation Rights, as described in Section 12.3, and sell-to-cover transactions) in any manner consistent with applicable
provisions of the Code, including, without limitation, by using the sale price of such shares on such date (or if sales of such shares
are effectuated at more than one sale price, the weighted average sale price of such shares on such date) as the Fair Market Value of
such shares, so long as such Grantee has provided the Company, or its designee or agent, with advance written notice of such sale.
2.22 “Family
Member” means, with respect to any Grantee as of any date of determination, (a) a person who is a spouse, former spouse,
child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother, sister, brother-in-law, or sister-in-law, including adoptive relationships, of such Grantee, (b) any person sharing such
Grantee’s household (other than a tenant or employee), (c) a trust in which any one or more of the persons specified in clauses
(a) and (b) above (and such Grantee) own more than 50% of the beneficial interest, (d) a foundation in which any one
or more of the persons specified in clauses (a) and (b) above (and such Grantee) control the management of assets, and (e) any
other entity in which one or more of the persons specified in clauses (a) and (b) above (and such Grantee) own more than 50% of
the voting interests.
2.23 “Grant
Date” means, as determined by the Committee, the latest to occur of (a) the date as of which the Committee approves the
Award, (b) the date on which the recipient of an Award first becomes eligible to receive an Award under Section 6 (e.g.,
in the case of a new hire, the first date on which such new hire performs any Service), or (c) such subsequent date specified by
the Committee in the corporate action approving the Award.
2.24 “Grantee”
means a person who receives or holds an Award under the Plan.
2.25 “Incentive
Stock Option” means an “incentive stock option” within the meaning of Code Section 422, or the corresponding
provision of any subsequently enacted tax statute, as amended from time to time.
2.26 “Non-Employee
Director” means a director of the Company who is not an Employee.
2.27 “Nonqualified
Stock Option” means an Option that is not an Incentive Stock Option.
2.28 “Option”
means an option to purchase one or more shares of Common Stock pursuant to the Plan.
2.29 “Option
Price” means the exercise price for each share of Common Stock subject to an Option.
2.30 “Other
Agreement” will have the meaning set forth in Section 15.
2.31 “Other
Equity-Based Award” means an Award representing a right or other interest that may be denominated or payable in, valued in whole
or in part by reference to, or otherwise based on, or related to, shares of Common Stock, other than an Option, a Stock Appreciation Right,
Restricted Stock, a Restricted Stock Unit, a Deferred Stock Unit, Unrestricted Stock, a Dividend Equivalent Right or a Performance Share.
2.32 “Parachute
Payment” will have the meaning set forth in Section 15.1(a).
2.33 “Performance-Based
Award” means an Award of an Option, a Stock Appreciation Right, Restricted Stock, Restricted Stock Units, Deferred Stock Units,
Performance Shares or an Other Equity-Based Award made subject to the achievement of performance goals (as provided in Section 14)
over a Performance Period specified by the Committee.
2.34 “Performance
Measures” means measures as specified in Section 14.8 on which the performance goals under Performance-Based Awards
are based. “Performance Period” means the period of time during which the performance goals under Performance-Based
Awards must be met to determine the degree of payout and/or vesting with respect to any such Performance-Based Awards.
2.35 “Performance
Shares” means a Performance-Based Award representing a right or other interest that may be denominated or payable in, valued
in whole or in part by reference to, or otherwise based on, or related to, shares of Common Stock, made subject to the achievement of
performance goals (as provided in Section 14) over a Performance Period of up to ten years.
2.36 “Plan”
means this Marinus Pharmaceuticals, Inc. 2024 Equity Incentive Plan, as amended from time to time.
2.37 “Prior
Plan” means the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended.
2.38 “Restricted
Period” will have the meaning set forth in Section 10.2.
2.39 “Restricted
Stock” means shares of Common Stock awarded to a Grantee pursuant to Section 10.
2.40 “Restricted
Stock Unit” means a bookkeeping entry representing the equivalent of one share of Common Stock awarded to a Grantee pursuant
to Section 10.
2.41 “Retirement”
means a Grantees’ voluntary termination of Service, other than while grounds for Cause exist, provided the Grantee is (a) at
least sixty (60) years of age and (b) has completed at least five (5) years of Service.
2.42 “SAR
Price” will have the meaning set forth in Section 9.1.
2.43 “Securities
Act” means the Securities Act of 1933, as amended, as now in effect or as hereafter amended.
2.44 “Service”
means service qualifying a Grantee as a Service Provider to the Company or an Affiliate. Unless otherwise provided in the applicable Award
Agreement, a Grantee’s change in position or duties will not result in interrupted or terminated Service, so long as such Grantee
continues to be a Service Provider to the Company or an Affiliate. Subject to the preceding sentence, any determination by the Committee
whether a termination of Service will have occurred for purposes of the Plan will be final, binding and conclusive. If a Service Provider’s
employment or other service relationship is with an Affiliate and the applicable entity ceases to be an Affiliate, a termination of Service
will be deemed to have occurred when such entity ceases to be an Affiliate unless the Service Provider transfers his or her employment
or other service relationship to the Company or any other Affiliate.
2.45 “Service
Provider” means an Employee, officer or director of the Company or an Affiliate, or any other service provider to the Company
or an Affiliate (including a consultant or advisor) who is a natural person, provided such person is currently providing direct services
to the Company or an Affiliate.
2.46 “Stock
Appreciation Right” or “SAR” means a right granted to a Grantee pursuant to Section 9.
2.47 “Stock
Exchange” means the Nasdaq Stock Market or another established national or regional stock exchange.
2.48 “Subsidiary”
means any corporation (other than the Company) or non-corporate entity with respect to which the Company owns, directly or indirectly,
50% or more of the total combined voting power of all classes of stock, membership interests or other ownership interests of any
class or kind ordinarily having the power to vote for the directors, managers or other voting members of the governing body of such corporation
or non-corporate entity. In addition, any other entity may be designated by the Committee as a Subsidiary, provided that (a) such
entity could be considered as a subsidiary according to U.S. generally accepted accounting principles, and (b) in the case of an
Award of an Option or a Stock Appreciation Right, such Award would be considered to be granted in respect of “service recipient
stock” under Code Section 409A.
2.49 “Substitute
Award” means an Award granted upon assumption of, or in substitution for, outstanding awards previously granted under a compensatory
plan by a business entity acquired or to be acquired by the Company or an Affiliate or with which the Company or an Affiliate has combined
or will combine.
2.50 “Ten
Percent Stockholder” means a natural person who owns more than ten percent of the total combined voting power of all classes
of outstanding voting securities of the Company, the Company’s parent (if any) or any of the Company’s Subsidiaries. In determining
share ownership, the attribution rules of Code Section 424(d) will be applied.
2.51 “Unrestricted
Stock” will have the meaning set forth in Section 11.
3. | ADMINISTRATION OF THE PLAN |
3.1 Committee.
(a) Powers
and Authorities.
The Committee will administer
the Plan and will have such powers and authorities related to the administration of the Plan as are consistent with the Company’s
certificate of incorporation and bylaws and Applicable Laws. Without limiting the generality of the foregoing, the Committee will have
full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award or any
Award Agreement, and will have full power and authority to take all such other actions and make all such other determinations not inconsistent
with the specific terms and provisions of the Plan that the Committee deems to be necessary or appropriate to the administration of the
Plan, any Award or any Award Agreement. All such actions and determinations will be made by (a) the affirmative vote of a majority
of the members of the Committee present at a meeting at which a quorum is present, or (b) the unanimous consent of the members of
the Committee executed in writing in accordance with the Company’s certificate of incorporation and bylaws and Applicable Laws.
Unless otherwise expressly determined by the Board, the Committee will have the authority to interpret and construe all provisions of
the Plan, any Award and any Award Agreement, and any such interpretation or construction, and any other determination contemplated to
be made under the Plan or any Award Agreement, by the Committee will be final, binding and conclusive whether or not expressly provided
for in any provision of the Plan, such Award or such Award Agreement.
In the event that the Plan,
any Award or any Award Agreement provides for any action to be taken by the Board or any determination to be made by the Board, such action
may be taken or such determination may be made by the Committee constituted in accordance with this Section 3.1 if the Board
has delegated the power and authority to do so to such Committee.
(b) Composition
of Committee.
The Committee will be a committee
composed of not fewer than two members of the Board designated by the Board to administer the Plan. During any time when the Company has
a class of equity security registered under Section 12 of the Exchange Act, each member of the Committee will be a “non-employee
director” within the meaning of Rule 16b-3 under the Exchange Act and an independent director in accordance with the rules of
any Stock Exchange on which the Common Stock is listed; provided that any action taken by the Committee will be valid and effective
whether or not members of the Committee at the time of such action are later determined not to have satisfied the requirements for membership
set forth in this Section 3.1(b) or otherwise provided in any charter of the Committee. Without limiting the generality
of the foregoing, the Committee may be the Compensation Committee of the Board or a subcommittee thereof if the Compensation Committee
of the Board or such subcommittee satisfies the foregoing requirements.
(c) Other
Committees.
The Board also may appoint
one or more committees of the Board, each composed of one or more directors of the Company who need not be Non-Employee Directors, which
committee may administer the Plan with respect to Grantees who are not “officers” as defined in Rule 16a-1(f) under
the Exchange Act or members of the Board, may grant Awards under the Plan to such Grantees, and may determine all terms of such Awards,
subject to the requirements of Rule 16b-3 under the Exchange Act and the rules of the Stock Exchange on which the Common Stock
is listed.
(d) Delegation
by Committee.
To the extent permitted by
Applicable Laws, the Committee may by resolution delegate some or all of its authority with respect to the Plan and Awards to the Chief
Executive Officer of the Company and/or any other officer of the Company designated by the Committee, provided that the Committee
may not delegate its authority hereunder (i) to make Awards to members of the Board, (ii) to make Awards to Employees who are
(A) “officers” as defined in Rule 16a-1(f) under the Exchange Act or (B) officers of the Company who are
delegated authority by the Committee pursuant to this Section 3.1(d), or (iii) to interpret the Plan or any Award. Any
delegation hereunder will be subject to the restrictions and limits that the Committee specifies at the time of such delegation or thereafter.
Nothing in the Plan will be construed as obligating the Committee to delegate authority to any officer of the Company, and the Committee
may at any time rescind the authority delegated to an officer of the Company appointed hereunder and delegate authority to one or more
other officers of the Company. At all times, an officer of the Company delegated authority pursuant to this Section 3.1(d) will
serve in such capacity at the pleasure of the Committee. Any action undertaken by any such officer of the Company in accordance with the
Committee’s delegation of authority will have the same force and effect as if undertaken directly by the Committee, and any reference
in the Plan to the “Committee” will, to the extent consistent with the terms and limitations of such delegation, be deemed
to include a reference to each such officer.
3.2 Board.
The Board from time to time
may exercise any or all of the powers and authorities related to the administration and implementation of the Plan, as set forth in Section 3.1
and other applicable provisions of the Plan, as the Board will determine, consistent with the Company’s certificate of incorporation
and bylaws and Applicable Laws.
3.3 Terms
of Awards.
(a) Committee
Authority.
Subject to the other terms
and conditions of the Plan, the Committee will have full and final authority to:
(i) designate
Grantees;
(ii) determine
the type or types of Awards to be made to a Grantee;
(iii) determine
the number of shares of Common Stock to be subject to an Award;
(iv) establish
the terms and conditions of each Award (including the Option Price of any Option or the purchase price for Restricted Stock), the nature
and duration of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture
of an Award or the shares of Common Stock subject thereto, the treatment of an Award in the event of a Change in Control (subject to applicable
agreements), and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options;
(v) prescribe
the form of each Award Agreement evidencing an Award; and
(vi) subject
to the limitation on repricing in Section 3.4, amend, modify or supplement the terms of any outstanding Award, which authority
will include the authority, in order to effectuate the purposes of the Plan but without amending the Plan, to make Awards or to modify
outstanding Awards made to eligible natural persons who are foreign nationals or are natural persons who are employed outside the United
States to reflect differences in local law, tax policy, or custom, provided that, notwithstanding the foregoing, no amendment,
modification or supplement of the terms of any outstanding Award will, without the consent of the Grantee thereof, impair such Grantee’s
rights under such Award.
(b) Forfeiture;
Recoupment.
The Committee may reserve
the right in an Award Agreement to cause a forfeiture of the gain realized by a Grantee with respect to an Award thereunder on account
of actions taken by, or failed to be taken by, such Grantee in violation or breach of or in conflict with any (i) employment agreement,
(ii) non-competition agreement, (iii) agreement prohibiting solicitation of Employees or clients of the Company or an Affiliate,
(iv) confidentiality obligation with respect to the Company or an Affiliate, (v) Company policy or procedure, (vi) other
agreement, or (vii) any other obligation of such Grantee to the Company or an Affiliate, as and to the extent specified in such Award
Agreement. The Committee may annul an outstanding Award if the Grantee is an Employee of the Company or an Affiliate and is terminated
for Cause as defined in the Plan or the applicable Award Agreement or for “cause” as defined in any other agreement between
the Company or such Affiliate and the Grantee, as applicable.
Any Award granted pursuant
to the Plan will be subject to mandatory repayment by the Grantee to the Company to the extent the Grantee is, or in the future becomes,
subject to (i) any Company “clawback” or recoupment policy that is adopted to comply with the requirements of any Applicable
Law, rule or regulation, or otherwise, or (ii) any law, rule or regulation that imposes mandatory recoupment, under circumstances
set forth in such law, rule or regulation.
3.4 Repricing.
Except in connection with
a corporate transaction involving the Company (including, without limitation, any stock dividend, distribution (whether in the form of
cash, shares of Common Stock, other securities or other property), stock split, extraordinary cash dividend, recapitalization, change
in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of shares of Common Stock or
other securities or similar transaction), the Company may not, without obtaining stockholder approval: (a) amend the terms of outstanding
Options or SARs to reduce the exercise price of such outstanding Options or the strike price of such outstanding SARs; (b) cancel
outstanding Options or SARs in exchange for or substitution of Options or SARs with an exercise price or strike price, as applicable,
that is less than the exercise price or strike price, as applicable, of the original Options or SARs; (c) cancel outstanding Options
or SARs with an exercise price or strike price, as applicable, above the current stock price in exchange for cash or other securities;
or (d) take any other action that is treated as a repricing under U.S. generally accepted accounting principles.
3.5 Deferral
Arrangement.
The Committee may permit
or require the deferral of any payment pursuant to any Award into a deferred compensation arrangement, subject to such rules and
procedures as it may establish, which may include provisions for the payment or crediting of interest or Dividend Equivalent Rights and,
in connection therewith, provisions for converting such credits into Deferred Stock Units and for restricting deferrals to comply with
hardship distribution rules affecting tax-qualified retirement plans subject to Code Section 401(k)(2)(B)(IV), provided
that no Dividend Equivalent Rights may be granted in connection with, or related to, an Award of Options or SARs. Any such deferrals will
be made in a manner that complies with Code Section 409A, including, if applicable, with respect to when a “separation from
service” (as defined for purposes of Code Section 409A) occurs.
3.6 No
Liability.
No member of the Board or
the Committee will be liable for any action or determination made in good faith with respect to the Plan or any Award or Award Agreement.
3.7 Registration;
Share Certificates.
Notwithstanding any provision
of the Plan to the contrary, the ownership of the shares of Common Stock issued under the Plan may be evidenced in such a manner as the
Committee, in its sole discretion, deems appropriate, including by book-entry or direct registration (including transaction advices) or
the issuance of one or more share certificates.
| 4. | Common STOCK SUBJECT TO THE PLAN |
4.1 Number
of Shares of Common Stock Available for Awards.
Subject to such additional
shares of Common Stock as will be available for issuance under the Plan pursuant to Section 4.2, and subject to adjustment
pursuant to Section 16, the maximum number of shares of Common Stock available for issuance under the Plan will be equal to
four million (4,000,000) shares of Common Stock plus any shares of Common Stock that would otherwise have become available for grant under
the Prior Plan after the Effective Date as a result of the termination or forfeiture of awards under the Prior Plan. Such shares of Common
Stock may be authorized and unissued shares of Common Stock or treasury shares of Common Stock or any combination of the foregoing, as
may be determined from time to time by the Board or by the Committee. Any of the shares of Common Stock available for issuance under the
Plan may be used for any type of Award under the Plan, and any or all of the shares of Common Stock available for issuance under the Plan
will be available for issuance pursuant to Incentive Stock Options.
4.2 Adjustments
in Authorized Shares of Common Stock.
In connection with mergers,
reorganizations, separations, or other transactions to which Code Section 424(a) applies, the Committee will have the right
to cause the Company to assume awards previously granted under a compensatory plan by another business entity that is a party to such
transaction and to substitute Awards under the Plan for such awards. The number of shares of Common Stock available for issuance under
the Plan pursuant to Section 4.1 will be increased by the number of shares of Common Stock subject to any such assumed Awards
and substitute Awards. Shares available for issuance under a stockholder-approved plan of a business entity that is a party to such transaction
(as appropriately adjusted, if necessary, to reflect such transaction) may be used for Awards under the Plan and will not reduce the number
of shares of Common Stock otherwise available for issuance under the Plan, subject to applicable rules of any Stock Exchange on which
the shares of Common Stock are listed.
4.3 Share
Usage.
(a) Shares
of Common Stock subject to an Award will be counted as used as of the Grant Date.
(b) Any
shares of Common Stock that are subject to Awards, including shares of Common Stock acquired through dividend reinvestment pursuant to
Section 10.4, will be counted against the share issuance limit set forth in Section 4.1 as one share of Common
Stock for every one share of Common Stock subject to such Award. Any shares of Common Stock that are subject to an Award of a SAR will
be counted against the share issuance limit set forth in Section 4.1 as one share of Common Stock for every one share of Common
Stock subject to such Award regardless of the number of shares of Common Stock actually issued to settle such SARs upon the exercise thereof.
The target number of shares issuable under a Performance Share grant will be counted against the share issuance limit set forth in Section 4.1
as of the Grant Date, but such number will be adjusted to equal the actual number of shares issued upon settlement of the Performance
Shares to the extent different from such target number of shares.
(c) Notwithstanding
anything to the contrary in Section 4.1, any shares of Common Stock related to Awards under the Plan that thereafter terminate
by expiration, forfeiture, cancellation, or otherwise without the issuance of such shares will be available again for issuance under the
Plan in the same amount as such shares were counted against the limit set forth in Section 4.1. Shares of Common Stock tendered
or withheld or subject to an Award other than an Option or SAR surrendered in connection with the purchase of shares of Common Stock or
deducted or delivered from payment of an Award other than an Option or SAR in connection with the Company’s tax withholding obligations
as provided in Section 18.3 will not be available again for issuance under the Plan.
(d) The
number of shares of Common Stock available for issuance under the Plan will not be increased by the number of shares of Common Stock (i) tendered
or withheld or subject to an Award surrendered in connection with the purchase of shares of Common Stock upon exercise of an Option as
provided in Section 12.2, (ii) deducted or delivered from payment of an Award of an Option or SAR in connection with
the Company’s tax withholding obligations as provided in Section 18.3 or (iii) purchased by the Company with proceeds
from Option exercises.
4.4 Non-Employee
Director Limit.
The maximum number of shares
of Common Stock that may be granted to any Non-Employee Director pursuant to Awards in any calendar year shall be limited to a number
that, combined with any cash fees or other compensation paid to such Non-Employee Director during such calendar year, shall not exceed
$750,000 in total value, with the value of any such Non-Employee Director Awards based on the grant date fair value of such Awards for
financial reporting purposes; provided, however, that in the calendar year in which a Nonemployee Director first joins the Board, the
aggregate limit for services as a member of the Board or a committee of the Board shall not exceed $1,000,000; provided, further, however,
that the foregoing limitations shall not apply to the extent that the Non-Employee Director has been or becomes an Employee during the
calendar year. For the avoidance of doubt, the limits in this subsection do not apply to compensation to a Non-Employee Director for service
to the Company other than service as a member of the Board or a committee of the Board.
| 5. | EFFECTIVE DATE; TERM; AMENDMENT AND TERMINATION |
5.1 Effective
Date.
The Plan will be effective
as of the Effective Date, subject to the approval of the Plan by the Company’s stockholders on such date. Following the Effective
Date, no awards shall be made under the Prior Plan. Notwithstanding the foregoing, shares of Common Stock reserved under the Prior Plan
to settle awards which are made under the Prior Plan prior to the Effective Date may be issued and delivered following the Effective Date
to settle such awards.
5.2 Term.
The Plan will terminate automatically
ten years after the Effective Date and may be terminated on any earlier date as provided in Section 5.3; provided, that Incentive
Stock Options may not be granted under the Plan after the tenth (10th) anniversary of the date of the Board’s adoption of the Plan.
5.3 Amendment
and Termination.
The Board may, at any time
and from time to time, amend, suspend or terminate the Plan as to any shares of Common Stock as to which Awards have not been made. The
effectiveness of any amendment to the Plan will be contingent on approval of such amendment by the Company’s stockholders to the
extent provided by the Board or required by Applicable Laws (including the rules of any Stock Exchange on which the shares of Common
Stock are then listed), provided that no amendment will be made to the no-repricing provisions of Section 3.4 or the
Option pricing provisions of Section 8.1 without the approval of the Company’s stockholders. No amendment, suspension
or termination of the Plan will impair rights or obligations under any outstanding Award made under the Plan without the Grantee’s
consent.
| 6. | AWARD ELIGIBILITY AND LIMITATIONS |
6.1 Eligible
Grantees.
Subject to this Section 6,
Awards may be made under the Plan to (a) any Service Provider, as the Committee will determine and designate from time to time and
(b) any other individual whose participation in the Plan is determined to be in the best interests of the Company by the Committee.
6.2 Stand-Alone,
Additional, Tandem and Substitute Awards.
Subject to Section 3.4,
Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in
substitution or exchange for, (a) any other Award, (b) any award granted under another plan of the Company, an Affiliate, or
any business entity that has been a party to a transaction with the Company or an Affiliate, or (c) any other right of a Grantee
to receive payment from the Company or an Affiliate. Such additional, tandem and substitute or exchange Awards may be granted at any time.
If an Award is granted in substitution or exchange for another Award, or for an award granted under another plan of the Company, an Affiliate,
or any business entity that has been a party to a transaction with the Company or an Affiliate, the Committee will require the surrender
of such other Award or award under such other plan in consideration for the grant of such substitute or exchange Award. In addition, Awards
may be granted in lieu of cash compensation, including in lieu of cash payments under other plans of the Company or an Affiliate. Notwithstanding
Section 8.1 and Section 9.1, but subject to Section 3.4, the Option Price of an Option or the SAR
Price of a SAR that is a Substitute Award may be less than 100% of the Fair Market Value of a share of Common Stock on the original
Grant Date; provided that such Option Price or SAR Price is determined in accordance with the principles of Code Section 424
for any Incentive Stock Option and consistent with Code Section 409A for any other Option or SAR.
Each Award granted pursuant
to the Plan will be evidenced by an Award Agreement, which will be in such form or forms as the Committee will from time to time determine.
Award Agreements utilized under the Plan from time to time or at the same time need not contain similar provisions, but will be consistent
with the terms of the Plan. Each Award Agreement evidencing an Award of an Option will specify whether the Option is intended to be a
Nonqualified Stock Option or an Incentive Stock Option, and, in the absence of such specification, the Option will be deemed to constitute
Nonqualified Stock Options.
| 8. | TERMS AND CONDITIONS OF OPTIONS |
8.1 Option
Price.
The Option Price of each
Option will be fixed by the Committee and stated in the Award Agreement evidencing such Option. Except in the case of Substitute Awards,
the Option Price of each Option will be at least the Fair Market Value of one share of Common Stock on the Grant Date; provided that
in the event that a Grantee is a Ten Percent Stockholder, the Option Price of an Option granted to such Grantee that is intended to be
an Incentive Share Option will be not less than 110% of the Fair Market Value of one share of Common Stock on the Grant Date. In
no case will the Option Price of any Option be less than the par value of a share of Common Stock.
8.2 Vesting.
Subject to Sections 8.3
and 17.3, each Option granted under the Plan will become exercisable at such times and under such conditions as will be determined
by the Committee and stated in the Award Agreement, in another agreement with the Grantee or otherwise in writing, provided that, except
as otherwise determined by the Committee, no Option will be granted to persons who are entitled to overtime under Applicable Laws, that
will vest or be exercisable within a six-month period starting on the Grant Date.
8.3 Term.
Each Option granted under
the Plan will terminate, and all rights to purchase shares of Common Stock thereunder will cease, upon the expiration of ten years from
the Grant Date of such Option, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed
by the Committee and stated in the Award Agreement relating to such Option; provided that in the event that the Grantee is a Ten
Percent Stockholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option will not be exercisable after
the expiration of five years from its Grant Date; and provided further, that, to the extent deemed necessary or appropriate by
the Committee to reflect differences in local law, tax policy, or custom with respect to any Option granted to a Grantee who is a foreign
national or is a natural person who is employed outside the United States, such Option may terminate, and all rights to purchase shares
of Common Stock thereunder may cease, upon the expiration of such period longer than ten years from the Grant Date of such Option as the
Committee will determine. The Company will deduct from the shares of Common Stock deliverable to the Grantee upon such exercise the number
of shares of Common Stock necessary to satisfy payment of the Option Price and all withholding obligations.
8.4 Termination
of Service.
(a) Each
Award Agreement with respect to the grant of an Option may set forth the extent to which the Grantee thereof, if at all, will have the
right to exercise such Option following termination of such Grantee’s Service. Such provisions will be determined in the sole discretion
of the Committee, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions based on the reasons
for termination of Service.
(b) Except
as otherwise provided in the applicable Award Agreement, following the date of termination of a Grantee’s Service for any reason
other than Disability, death, Retirement or termination for Cause, any Option that is otherwise exercisable by the Grantee as of the date
of termination of such Grantee’s Service shall terminate unless exercised within ninety (90) days following the date of termination
of such Grantee’s Service, but in any event no later than the date of expiration of the Option term. Except as otherwise provided
in the applicable Award Agreement, any of the Grantee’s Options that are not otherwise exercisable as of the date of termination
of a Grantee’s Service shall terminate as of such date.
(c) Except
as otherwise provided in the applicable Award Agreement, in the event of the termination of a Grantee’s Service on account of a
termination for Cause, any Option held by the Grantee shall terminate as of the date of termination of the Grantee’s Service. In
addition, notwithstanding any other provisions of this Section 8.4, if the Committee determines that the Grantee has engaged
in conduct that constitutes Cause at any time during the Grantee’s Service or after the termination of such Grantee’s Service,
any Option held by the Grantee shall immediately terminate, and the Grantee shall automatically forfeit all shares underlying any exercised
portion of an Option for which the Company has not yet delivered the share certificates, upon refund by the Company of the Option Price
paid by the Grantee for such shares. Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution
of an inquiry that could lead to a finding resulting in a forfeiture.
(d) Except
as otherwise provided in the applicable Award Agreement, in the event of the termination of a Grantee’s Service on account of the
Grantee’s Disability, any Option that is otherwise exercisable by the Grantee shall terminate unless exercised within one (1) year
after the date of termination of the Grantee’s Service, but in any event no later than the date of expiration of the Option term.
Except as otherwise provided in the applicable Award Agreement, any of the Grantee’s Options that are not otherwise exercisable
as of the date of the termination of a Grantee’s Service, shall terminate as of such date. In the event that an Incentive Stock
Option is exercised more than ninety (90) days after the date of the termination of a Grantee’s Service, the Option shall lose its
status as an Incentive Stock Option and shall be treated as a Nonqualified Stock Option.
(e) Except
as otherwise provided in the applicable Award Agreement, in the event of the termination of a Grantee’s Service on account of the
Grantee’s death, or in the event of the Grantee’s death within ninety (90) days after the date of termination of a Grantee’s
Service on account of a termination specified in Section 8.4(b) above, any Option that is otherwise exercisable by the
Grantee shall terminate unless exercised within one (1) year after the date of termination of a Grantee’s Service, but in any
event no later than the date of expiration of the Option term. Except as otherwise provided in the applicable Award Agreement, any of
the Grantee’s Options that are not otherwise exercisable as of the date of termination of a Grantee’s Service shall terminate
as of such date.
(f) Except
as otherwise provided in the applicable Award Agreement, in the event of the termination of a Grantee’s Service on account of the
Grantee’s Retirement, any Option that is otherwise exercisable by the Grantee shall terminate unless exercised within one (1) year
after the date of termination of the Grantee’s Service, but in any event no later than the date of expiration of the Option term.
Except as otherwise provided in the applicable Award Agreement, any of the Grantee’s Options that are not otherwise exercisable
as of the date of the termination of a Grantee’s Service, shall terminate as of such date. In the event that an Incentive Stock
Option is exercised more than ninety (90) days after the date of the termination of a Grantee’s Service, the Option shall lose its
status as an Incentive Stock Option and shall be treated as a Nonqualified Stock Option.
8.5 Limitations
on Exercise of Option.
Notwithstanding any other
provision of the Plan, in no event may any Option be exercised, in whole or in part, after the occurrence of an event referred to in Section 17
that results in the termination of such Option.
8.6 Method
of Exercise.
Subject to the terms of Section 12
and Section 18.3, an Option that is exercisable may be exercised by the Grantee’s delivery to the Company or its
designee or agent a notice of exercise on any business day, at the Company’s principal office or the office of such designee or
agent, on the form specified by the Company and in accordance with any additional procedures specified by the Committee. The notice of
exercise will specify the number of shares of Common Stock with respect to which such Option is being exercised and will be accompanied
by payment in full of the Option Price of the shares of Common Stock for which such Option is being exercised plus the amount (if any)
of federal and/or other taxes that the Company may, in its discretion, be required to withhold with respect to the exercise of such Option.
8.7 Rights
of Holders of Options.
Unless otherwise stated in
the applicable Award Agreement, a Grantee or other person holding or exercising an Option will have none of the rights of a stockholder
of the Company (for example, the right to receive cash or dividend payments or distributions attributable to the shares of Common Stock
subject to such Option, to direct the voting of the shares of Common Stock subject to such Option, or to receive notice of any meeting
of the Company’s stockholders) until the shares of Common Stock subject thereto are fully paid and issued to such Grantee or other
person. Except as provided in Section 17, no adjustment will be made for dividends, distributions or other rights with respect
to any shares of Common Stock subject to an Option for which the record date is prior to the date of issuance of such shares of Common
Stock.
8.8 Delivery
of Shares of Common Stock.
Promptly after the exercise
of an Option by a Grantee and the payment in full of the Option Price with respect thereto, such Grantee will be entitled to receive such
evidence of such Grantee’s ownership of the shares of Common Stock subject to such Option as will be consistent with Section 3.7.
8.9 Transferability
of Options.
Except as provided in Section 8.10,
during the lifetime of a Grantee of an Option, only such Grantee (or, in the event of such Grantee’s legal incapacity or incompetency,
such Grantee’s guardian or legal representative) may exercise such Option. Except as provided in Section 8.10, no Option
will be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution.
8.10 Family
Transfers.
If authorized in the applicable
Award Agreement and by the Committee, in its sole discretion, a Grantee may transfer, not for value, all or part of an Option that is
not an Incentive Stock Option to any Family Member. For the purpose of this Section 8.10, a transfer “not for value”
is a transfer that is (a) a gift, (b) a transfer under a domestic relations order in settlement of marital property rights or
(c) unless Applicable Laws do not permit such transfer, a transfer to an entity in which more than 50% of the voting interests
are owned by Family Members (and/or the Grantee) in exchange for an interest in such entity. Following a transfer under this Section 8.10,
any such Option will continue to be subject to the same terms and conditions as were applicable immediately prior to such transfer, and
the shares of Common Stock acquired pursuant to such Option will be subject to the same restrictions with respect to transfers of such
shares of Common Stock as would have applied to the Grantee thereof. Subsequent transfers of transferred Options will be prohibited except
to Family Members of the original Grantee in accordance with this Section 8.10 or by will or the laws of descent and distribution.
The provisions of Section 8.4 relating to termination of Service will continue to be applied with respect to the original
Grantee of the Option, following which such Option will be exercisable by the transferee only to the extent, and for the periods specified,
in Section 8.4.
8.11 Limitations
on Incentive Stock Options.
An Option will constitute
an Incentive Stock Option only (a) if the Grantee of such Option is an Employee of the Company or any corporate Subsidiary, (b) to
the extent specifically provided in the related Award Agreement and (c) to the extent that the aggregate Fair Market Value (determined
at the time such Option is granted) of the shares of Common Stock with respect to which all Incentive Stock Options held by such Grantee
become exercisable for the first time during any calendar year (under the Plan and all other plans of the Company and its Affiliates)
does not exceed $100,000. Except to the extent provided in the regulations under Code Section 422, this limitation will be applied
by taking Options into account in the order in which they were granted.
8.12 Notice
of Disqualifying Disposition.
If any Grantee makes any
disposition of shares of Common Stock issued pursuant to the exercise of an Incentive Stock Option under the circumstances provided in
Code Section 421(b) (relating to certain disqualifying dispositions), such Grantee will notify the Company of such disposition
within ten days thereof.
| 9. | TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS |
9.1 Right
to Payment and Grant Price.
A SAR will confer on the
Grantee to whom it is granted a right to receive, upon exercise thereof, the excess of (a) the Fair Market Value of one share of
Common Stock on the date of exercise and (b) the per share strike price of such SAR (the “SAR Price”) as determined
by the Committee. The Award Agreement for a SAR will specify the SAR Price, which will be no less than the Fair Market Value of one share
of Common Stock on the Grant Date of such SAR. SARs may be granted in tandem with all or part of an Option granted under the Plan or at
any subsequent time during the term of such Option, in combination with all or any part of any other Award or without regard to any Option
or other Award; provided that a SAR that is granted subsequent to the Grant Date of a related Option must have a SAR Price that
is no less than the Fair Market Value of one share of Common Stock on the Grant Date of such SAR.
9.2 Other
Terms.
The Committee will determine
on the Grant Date or thereafter the time or times at which and the circumstances under which a SAR may be exercised in whole or in part
(including based on achievement of performance goals and/or future Service requirements), the time or times at which SARs will cease to
be or become exercisable following termination of Service or upon other conditions, the method of exercise, method of settlement, form
of consideration payable in settlement, method by or forms in which shares of Common Stock will be delivered or deemed to be delivered
to Grantees, whether or not a SAR will be granted in tandem or in combination with any other Award, and any and all other terms and conditions
of any SAR.
9.3 Term.
Each SAR granted under the
Plan will terminate, and all rights thereunder will cease, upon the expiration of ten years from the Grant Date of such SAR or under such
circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Committee and stated in the Award Agreement
relating to such SAR. If on the day preceding the date on which a Grantee’s SAR would otherwise terminate, the Fair Market Value
of the shares of Common Stock underlying a Grantee’s SAR is greater than the SAR Price, the Company will, prior to the termination
of such SAR and without any action being taken on the part of the Grantee, consider such SAR to have been exercised by the Grantee.
9.4 Transferability
of SARS.
Except as provided in Section 9.5,
during the lifetime of a Grantee of a SAR, only the Grantee (or, in the event of such Grantee’s legal incapacity or incompetency,
such Grantee’s guardian or legal representative) may exercise such SAR. Except as provided in Section 9.5, no SAR will
be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution.
9.5 Family
Transfers.
If authorized in the applicable
Award Agreement and by the Committee, in its sole discretion, a Grantee may transfer, not for value, all or part of a SAR to any Family
Member. For the purpose of this Section 9.5, a transfer “not for value” is a transfer that is (a) a gift,
(b) a transfer under a domestic relations order in settlement of marital property rights or (c) unless Applicable Laws do not
permit such transfer, a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (and/or
the Grantee) in exchange for an interest in such entity. Following a transfer under this Section 9.5, any such SAR will continue
to be subject to the same terms and conditions as were in effect immediately prior to such transfer, and shares of Common Stock acquired
pursuant to a SAR will be subject to the same restrictions on transfers of such shares of Common Stock as would have applied to the Grantee
or such SAR. Subsequent transfers of transferred SARs will be prohibited except to Family Members of the original Grantee in accordance
with this Section 9.5 or by will or the laws of descent and distribution.
| 10. | TERMS AND CONDITIONS OF RESTRICTED STOCK, RESTRICTED STOCK
UNITS and Deferred STOCK Units |
10.1 Grant
of Restricted Stock, Restricted Stock Units and Deferred Stock Units.
Awards of Restricted Stock,
Restricted Stock Units and Deferred Stock Units may be made for consideration or for no consideration, other than the par value of the
shares of Common Stock, which will be deemed paid by past Service or, if so provided in the related Award Agreement or a separate agreement,
the promise by the Grantee to perform future Service to the Company or an Affiliate.
10.2 Restrictions.
At the time a grant of Restricted
Stock, Restricted Stock Units or Deferred Stock Units is made, the Committee may, in its sole discretion, (a) establish a period
of time (a “Restricted Period”) applicable to such Restricted Stock, Restricted Stock Units or Deferred Stock Units
and (b) prescribe restrictions in addition to or other than the expiration of the Restricted Period, including the achievement of
corporate or individual performance goals, which may be applicable to all or any portion of such Award of Restricted Stock, Restricted
Stock Units or Deferred Stock Units as provided in Section 14. Awards of Restricted Stock, Restricted Stock Units and Deferred
Stock Units may not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the Restricted Period or prior
to the satisfaction of any other restrictions prescribed by the Committee with respect to such Awards.
10.3 Registration;
Restricted Stock Certificates.
Pursuant to Section 3.7,
to the extent that ownership of Restricted Stock is evidenced by a book-entry registration or direct registration (including transaction
advices), such registration will be notated to evidence the restrictions imposed on such Award of Restricted Stock under the Plan and
the applicable Award Agreement. Subject to Section 3.7 and the immediately following sentence, the Company may issue, in the
name of each Grantee to whom Restricted Stock has been granted, share certificates representing the total number of shares of Restricted
Stock granted to the Grantee, as soon as reasonably practicable after the Grant Date of such Restricted Stock. The Committee may provide
in an Award Agreement with respect to an Award of Restricted Stock that either (a) the Secretary of the Company will hold such share
certificates for such Grantee’s benefit until such time as such shares of Restricted Stock are forfeited to the Company or the restrictions
applicable thereto lapse and such Grantee will deliver a stock power to the Company with respect to each share certificate, or (b) such
share certificates will be delivered to such Grantee, provided that such share certificates will bear legends that comply with
applicable securities laws and regulations and make appropriate reference to the restrictions imposed on such Award of Restricted Stock
under the Plan and such Award Agreement.
10.4 Rights
of Holders of Restricted Stock.
Unless the Committee otherwise
provides in an Award Agreement, holders of Restricted Stock will have the right to vote such shares of Restricted Stock and the right
to receive any dividends declared or paid with respect to such shares of Restricted Stock. The Committee may provide that any dividends
paid on Restricted Stock must be reinvested in shares of Common Stock, which shall be subject to the same vesting conditions and restrictions
as the vesting conditions and restrictions applicable to such Restricted Stock. Dividends paid on Restricted Stock that vests or is earned
based upon the achievement of performance goals will not vest unless such performance goals for such Restricted Stock are achieved, and
if such performance goals are not achieved, the Grantee of such Restricted Stock will promptly forfeit and repay to the Company such dividend
payments, if permissible under Applicable Law. All share distributions, if any, received by a Grantee with respect to Restricted Stock
as a result of any stock split, stock dividend, combination of stock, or other similar transaction will be subject to the vesting conditions
and restrictions applicable to such Restricted Stock. No election under Section 83(b) of the Code or under a similar provision
of law may be made unless expressly permitted by the terms of the applicable Award agreement or by action of the Committee in writing
prior to the making of such election. If a Grantee, in connection with the acquisition of shares of Common Stock under the Plan or otherwise,
is expressly permitted to make such election and the Grantee makes the election, the Grantee shall notify the Company of such election
within ten days of filing notice of the election with the Internal Revenue Service or other governmental authority, in addition to any
filing and notification required pursuant to Section 83(b) of the Code or other applicable provision.
10.5 Rights
of Holders of Restricted Stock Units and Deferred Stock Units.
(a) Voting
and Dividend Rights.
Holders of Restricted Stock
Units and Deferred Stock Units will have no rights as stockholders of the Company (for example, the right to receive cash or dividend
payments or distributions attributable to the shares of Common Stock subject to such Restricted Stock Units and Deferred Stock Units,
to direct the voting of the shares of Common Stock subject to such Restricted Stock Units and Deferred Stock Units, or to receive notice
of any meeting of the Company’s stockholders). The Committee may provide in an Award Agreement evidencing a grant of Restricted
Stock Units or Deferred Stock Units that the holder of such Restricted Stock Units or Deferred Stock Units will be entitled to receive,
upon the Company’s payment of a cash dividend on its outstanding shares of Common Stock, a cash payment for each such Restricted
Stock Unit or Deferred Stock Unit that is equal to the per-share dividend paid on such shares of Common Stock. Dividends paid on Restricted
Stock Units and Deferred Stock Units that vest or are earned based upon the achievement of performance goals will not vest unless such
performance goals for such Restricted Stock Units or Deferred Stock Units are achieved, and if such performance goals are not achieved,
the Grantee of such Restricted Stock Units or Deferred Stock Units will promptly forfeit and repay to the Company such dividend payments,
if permissible under Applicable Law. Such Award Agreement also may provide that such cash payment will be deemed reinvested in additional
Restricted Stock Units or Deferred Stock Units at a price per unit equal to the Fair Market Value of a share of Common Stock on the date
on which such cash dividend is paid. Such cash payments paid in connection with Restricted Stock Units or Deferred Stock Units that vest
or are earned based upon the achievement of performance goals will not vest unless such performance goals for such Restricted Stock Units
or Deferred Stock Units are achieved, and if such performance goals are not achieved, the Grantee of such Restricted Stock Units or Deferred
Stock Units will promptly forfeit and repay to the Company such cash payments, if permissible under Applicable Law.
(b) Creditor’s
Rights.
A holder of Restricted Stock
Units or Deferred Stock Units will have no rights other than those of a general unsecured creditor of the Company. Restricted Stock Units
and Deferred Stock Units represent unfunded and unsecured obligations of the Company, subject to the terms and conditions of the applicable
Award Agreement.
10.6 Termination
of Service.
Unless the Committee otherwise
provides in an Award Agreement, in another agreement with the Grantee or otherwise in writing after such Award Agreement is entered into,
but prior to termination of Grantee’s Service, upon the termination of such Grantee’s Service, any Restricted Stock, Restricted
Stock Units or Deferred Stock Units held by such Grantee that have not vested, or with respect to which all applicable restrictions and
conditions have not lapsed, will immediately be deemed forfeited. Upon forfeiture of such Restricted Stock, Restricted Stock Units or
Deferred Stock Units, the Grantee thereof will have no further rights with respect thereto, including any right to vote such Restricted
Stock or any right to receive dividends with respect to such Restricted Stock, Restricted Stock Units or Deferred Stock Units.
10.7 Purchase
of Restricted Stock and Shares of Common Stock Subject to Restricted Stock Units and Deferred Stock Units.
The Grantee of an Award of
Restricted Stock, vested Restricted Stock Units or vested Deferred Stock Units will be required, to the extent required by Applicable
Laws, to purchase such Restricted Stock or the shares of Common Stock subject to such vested Restricted Stock Units or Deferred Stock
Units from the Company at a purchase price equal to the greater of (x) the aggregate par value of the shares of Common Stock represented
by such Restricted Stock or such vested Restricted Stock Units or Deferred Stock Units or (y) the purchase price, if any, specified
in the Award Agreement relating to such Restricted Stock or such vested Restricted Stock Units or Deferred Stock Units. Such purchase
price will be payable in a form provided in Section 12 or, in the sole discretion of the Committee, in consideration for Service
rendered or to be rendered to the Company or an Affiliate.
10.8 Delivery
of Shares of Common Stock.
Upon the expiration or termination
of any Restricted Period and the satisfaction of any other conditions prescribed by the Committee, including but not limited to any delayed
delivery period, the restrictions applicable to Restricted Stock, Restricted Stock Units or Deferred Stock Units settled in shares of
Common Stock will lapse, and, unless otherwise provided in the applicable Award Agreement, a book-entry or direct registration (including
transaction advices) or a share certificate evidencing ownership of such shares of Common Stock will, consistent with Section 3.7,
be issued, free of all such restrictions, to the Grantee thereof or such Grantee’s beneficiary or estate, as the case may be. Neither
the Grantee, nor the Grantee’s beneficiary or estate, will have any further rights with regard to a Restricted Stock Unit or Deferred
Stock Unit once the shares of Common Stock represented by such Restricted Stock Unit or Deferred Stock Unit have been delivered in accordance
with this Section 10.8.
| 11. | TERMS AND CONDITIONS OF UNRESTRICTED STOCK AWARDS AND OTHER
AWARDS |
11.1 Unrestricted
Stock Awards.
The Committee may, in its
sole discretion, grant (or sell at the par value of a share of Common Stock or at such other higher purchase price as will be determined
by the Committee) an Award to any Grantee pursuant to which such Grantee may receive shares of Common Stock free of any restrictions (“Unrestricted
Stock”) under the Plan. Unrestricted Stock may be granted or sold to any Grantee as provided in the immediately preceding sentence
in respect of past Service or, if so provided in the related Award Agreement or a separate agreement, the promise by the Grantee to perform
future Service, to the Company or an Affiliate or other valid consideration, or in lieu of, or in addition to, any cash compensation due
to such Grantee.
11.2 Other
Awards.
The Committee may, in its
sole discretion, grant Awards in the form of Other Equity-Based Awards, as deemed by the Committee to be consistent with the purposes
of the Plan. Awards granted pursuant to this Section 11.2 may be granted with vesting, value and/or payment contingent upon
the achievement of one or more performance goals. The Committee will determine the terms and conditions of Other Equity-Based Awards
at the Grant Date or thereafter. Unless the Committee otherwise provides in an Award Agreement, in another agreement with the Grantee,
or otherwise in writing after such Award Agreement is issued, upon the termination of a Grantee’s Service, any Other Equity-Based
Awards held by such Grantee that have not vested, or with respect to which all applicable restrictions and conditions have not lapsed,
will immediately be deemed forfeited. Upon forfeiture of any Other Equity-Based Award, the Grantee thereof will have no further rights
with respect to such Other Equity-Based Award.
| 12. | FORM OF
PAYMENT FOR OPTIONS AND RESTRICTED STOCK |
12.1 General
Rule.
Payment of the Option Price
for the shares of Common Stock purchased pursuant to the exercise of an Option or the purchase price, if any, for Restricted Stock will
be made in cash or in cash equivalents acceptable to the Company.
12.2 Surrender
of Shares of Common Stock.
To the extent that the applicable
Award Agreement so provides, payment of the Option Price for shares of Common Stock purchased pursuant to the exercise of an Option or
the purchase price, if any, for Restricted Stock may be made all or in part through the tender or attestation to the Company of shares
of Common Stock, which will be valued, for purposes of determining the extent to which such Option Price or purchase price has been paid
thereby, at their Fair Market Value on the date of such tender or attestation.
12.3 Cashless
Exercise.
To the extent permitted
by Applicable Laws and to the extent the Award Agreement so provides, payment of the Option Price for shares of Common Stock purchased
pursuant to the exercise of an Option may be made all or in part by delivery (on a form acceptable to the Committee) of an irrevocable
direction to a licensed securities broker acceptable to the Company to sell shares of Common Stock and to deliver all or part of the
proceeds of such sale to the Company in payment of such Option Price and any withholding taxes described in Section 18.3,
or, with the consent of the Company, by issuing the number of shares of Common Stock equal in value to the difference between such Option
Price and the Fair Market Value of the shares of Common Stock subject to the portion of such Option being exercised.
12.4 Other
Forms of Payment.
To the extent the Award
Agreement so provides and/or unless otherwise specified in an Award Agreement, payment of the Option Price for shares of Common Stock
purchased pursuant to exercise of an Option or the purchase price, if any, for Restricted Stock may be made in any other form that is
consistent with Applicable Laws, including (a) Service by the Grantee thereof to the Company or an Affiliate and (b) by withholding
shares of Common Stock that would otherwise vest or be issuable in an amount equal to the Option Price or purchase price and the required
tax withholding amount.
| 13. | TERMS
AND CONDITIONS OF DIVIDEND EQUIVALENT RIGHTS |
13.1 Dividend
Equivalent Rights.
A Dividend Equivalent Right
is an Award entitling the Grantee thereof to receive credits based on cash distributions that would have been paid on the shares of Common
Stock specified in such Dividend Equivalent Right (or other Award to which such Dividend Equivalent Right relates) if such shares of
Common Stock had been issued to and held by the recipient of such Dividend Equivalent Right as of the record date. A Dividend Equivalent
Right may be granted hereunder to any Grantee, provided that no Dividend Equivalent Rights may be granted in connection with,
or related to, an Award of an Option or a SAR. The terms and conditions of Dividend Equivalent Rights will be specified in the Award
Agreement therefor. Dividend equivalents credited to the holder of a Dividend Equivalent Right may be deemed to be reinvested in additional
shares of Common Stock, which may thereafter accrue additional Dividend Equivalent Rights (with or without being subject to forfeiture
or a repayment obligation). Any such reinvestment will be at the Fair Market Value thereof on the date of such reinvestment. Dividend
Equivalent Rights may be settled in cash or shares of Common Stock or a combination thereof, in a single installment or in multiple installments,
all as determined in the sole discretion of the Committee. A Dividend Equivalent Right granted as a component of another Award may provide
that such Dividend Equivalent Right will be settled upon exercise, settlement, or payment of, or lapse of restrictions on, such other
Award, and that such Dividend Equivalent Right will expire or be forfeited or annulled under the same conditions as such other Award.
A Dividend Equivalent Right granted as a component of another Award also may contain terms and conditions that are different from the
terms and conditions of such other Award, provided that Dividend Equivalent Rights credited pursuant to a Dividend Equivalent
Right granted as a component of another Award will not vest or become payable unless and until the Award to which the Dividend Equivalent
Rights correspond becomes vested and settled.
13.2 Termination
of Service.
Unless the Committee otherwise
provides in an Award Agreement, in another agreement with the Grantee, or otherwise in writing after such Award Agreement is issued,
a Grantee’s rights in all Dividend Equivalent Rights will automatically terminate upon such Grantee’s termination of Service
for any reason.
| 14. | TERMS
AND CONDITIONS OF PERFORMANCE-BASED AWARDS |
14.1 Grant
of Performance-Based Awards.
Subject to the terms and
provisions of the Plan, the Committee, at any time and from time to time, may grant Performance-Based Awards to a Plan participant in
such amounts and upon such terms as the Committee will determine.
14.2 Value
of Performance-Based Awards.
Each grant of a Performance-Based
Award will have an actual or target number of shares of Common Stock or initial value that is established by the Committee at the time
of grant. The Committee will set performance goals in its discretion that, depending on the extent to which they are achieved, will determine
the value and/or number of shares of Common Stock subject to a Performance-Based Award that will be paid out to the Grantee thereof.
14.3 Earning
of Performance-Based Awards.
Subject to the terms of
the Plan, in particular Section 14.7, after the applicable Performance Period has ended, the Grantee of Performance-Based
Awards will be entitled to receive a payout on the number of shares of Common Stock or cash value earned under the Performance-Based
Awards by such Grantee over such Performance Period.
14.4 Form and
Timing of Payment of Performance-Based Awards.
Payment of earned Performance-Based
Awards will be made in the manner described in the applicable Award Agreement as determined by the Committee. Subject to the terms of
the Plan, the Committee, in its sole discretion, may pay earned Performance-Based Awards in the form of cash or shares of Common Stock
(or a combination thereof) equal to the value of such earned Performance-Based Awards and will pay the Awards that have been earned at
the close of the applicable Performance Period, or as soon as reasonably practicable after the Committee has determined that the performance
goal or goals relating thereto have been achieved; provided that, unless specifically provided in the Award Agreement for such
Awards, such payment will occur no later than the 15th day of the third month following the end of the calendar year in which such Performance
Period ends. Any shares of Common Stock paid out under such Performance-Based Awards may be granted subject to any restrictions deemed
appropriate by the Committee. The determination of the Committee with respect to the form of payout of such Performance-Based Awards
will be set forth in the Award Agreement therefor.
14.5 Performance
Conditions.
The right of a Grantee to
exercise or receive a grant or settlement of any Performance-Based Award, and the timing thereof, may be subject to such performance
conditions as may be specified by the Committee. The Committee may use such business criteria and other measures of performance as it
may deem appropriate in establishing any performance conditions.
14.6 Performance
Goals Generally.
The performance goals for
Performance-Based Awards will consist of one or more business criteria and a targeted level or levels of performance with respect to
each of such criteria, as specified by the Committee consistent with this Section 14.6. The Committee may determine that
such Awards will be granted, exercised and/or settled upon achievement of any single performance goal or of two or more performance goals.
Performance goals may differ for Awards granted to any one Grantee or to different Grantees.
14.7 Payment
of Awards; Other Terms.
Payment of Performance-Based
Awards will be in cash, shares of Common Stock, or other Awards, including an Award that is subject to additional Service-based vesting,
as determined in the sole discretion of the Committee. The Committee may, in its sole discretion, reduce the amount of a payment otherwise
to be made in connection with such Awards. The Committee will specify the circumstances in which such Performance-Based Awards will be
paid or forfeited in the event of termination of Service by the Grantee prior to the end of a Performance Period or settlement of such
Awards. In the event payment of the Performance-Based Award is made in the form of another Award subject to Service-based vesting, the
Committee will specify the circumstances in which the payment Award will be paid or forfeited in the event of a termination of Service.
14.8 Performance
Measures.
The Committee may establish
Performance Measures and the level of achievement versus such Performance Measures that may determine the number of shares of Common
Stock to be granted, retained, vested, issued or issuable under or in settlement of or the amount payable pursuant to an Award, which
Performance Measures may include any one or more standards of the performance of the Company, its Subsidiaries or Affiliates, or any
portion thereof or individual performance factors as the Committee shall determine, in its sole discretion. Performance under any Performance
Measures (a) may be used to measure the performance of (i) the Company and its Subsidiaries and other Affiliates as a whole,
(ii) the Company, any Subsidiary, and/or any other Affiliate or any combination thereof, or (iii) any one or more business
units of the Company, any Subsidiary, and/or any other Affiliate, as the Committee, in its sole discretion, deems appropriate and (b) may
be compared to the performance of one or more other companies or one or more published or special indices designated or approved by the
Committee for such comparison, as the Committee, in its sole discretion, deems appropriate. The Committee also will have the authority
to provide for accelerated vesting of any Performance-Based Award based on the achievement of performance goals pursuant to the Performance
Measures.
14.9 Evaluation
of Performance.
The Committee may provide
in any Performance-Based Award that any evaluation of performance may include or exclude any of the following events that occur during
a Performance Period: (a) asset write-downs; (b) litigation or claims, judgments or settlements; (c) the effect of changes
in tax laws, accounting principles or other laws or provisions affecting reported results; (d) any reorganization or restructuring
events or programs; (e) extraordinary, non-core, non-operating or non-recurring items; (f) acquisitions or divestitures; and
(g) foreign exchange gains and losses.
15.1 General
If any Grantee is a “disqualified
individual,” as defined in Code Section 280G(c), then, notwithstanding any other provision of the Plan or of any other agreement,
contract, or understanding heretofore or hereafter entered into by such Grantee with the Company or an Affiliate, except an agreement,
contract, or understanding that expressly addresses Code Section 280G or Code Section 4999 (an “Other Agreement”),
and notwithstanding any formal or informal plan or other arrangement for the direct or indirect provision of compensation to the Grantee
(including groups or classes of Grantees or beneficiaries of which the Grantee is a member), whether or not such compensation is deferred,
is in cash, or is in the form of a benefit to or for the Grantee (a “Benefit Arrangement”), any right of the Grantee
to any exercise, vesting, payment, or benefit under the Plan will be reduced or eliminated:
(a) to
the extent that such right to exercise, vesting, payment, or benefit, taking into account all other rights, payments, or benefits to
or for the Grantee under the Plan, all Other Agreements, and all Benefit Arrangements, would cause any exercise, vesting, payment, or
benefit to the Grantee under the Plan to be considered a “parachute payment” within the meaning of Code Section 280G(b)(2) as
then in effect (a “Parachute Payment”); and
(b) if,
as a result of receiving such Parachute Payment, the aggregate after-tax amounts received by the Grantee from the Company under the Plan,
all Other Agreements, and all Benefit Arrangements would be less than the maximum after-tax amount that could be received by the Grantee
without causing any such payment or benefit to be considered a Parachute Payment.
The Company will accomplish
such reduction by first reducing or eliminating any cash payments (with the payments to be made furthest in the future being reduced
first), then by reducing or eliminating any accelerated vesting of Performance-Based Awards, then by reducing or eliminating any accelerated
vesting of Options or SARs, then by reducing or eliminating any accelerated vesting of Restricted Stock, Restricted Stock Units or Deferred
Stock Units, then by reducing or eliminating any other remaining Parachute Payments.
16.1 General.
The Company will not be
required to offer, sell or issue any shares of Common Stock under any Award, whether pursuant to the exercise of an Option or SAR or
otherwise, if the offer, sale or issuance of such shares of Common Stock would constitute a violation by the Grantee, the Company or
an Affiliate, or any other person, of any provision of Applicable Laws, including any federal or state securities laws or regulations.
If at any time the Company will determine, in its discretion, that the listing, registration or qualification of any shares of Common
Stock subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition
of, or in connection with, the offering, issuance, sale or purchase of shares of Common Stock in connection with any Award, no shares
of Common Stock may be offered, issued or sold to the Grantee or any other person under such Award, whether pursuant to the exercise
of an Option or SAR or otherwise, unless such listing, registration or qualification will have been effected or obtained free of any
conditions not acceptable to the Company, and any delay caused thereby will in no way affect the date of termination of such Award. Without
limiting the generality of the foregoing, upon the exercise of any Option or any SAR that may be settled in shares of Common Stock or
the delivery of any shares of Common Stock underlying an Award, unless a registration statement under the Securities Act is in effect
with respect to the shares of Common Stock subject to such Award, the Company will not be required to offer, sell or issue such shares
of Common Stock unless the Committee will have received evidence satisfactory to it that the Grantee or any other person exercising such
Option or SAR or accepting delivery of such shares may acquire such shares of Common Stock pursuant to an exemption from registration
under the Securities Act. Any determination in this connection by the Committee will be final, binding, and conclusive. The Company may
register, but will in no event be obligated to register, any shares of Common Stock Or other securities issuable pursuant to the Plan
pursuant to the Securities Act. The Company will not be obligated to take any affirmative action in order to cause the exercise of an
Option or a SAR or the issuance of shares of Common Stock or other securities issuable pursuant to the Plan or any Award to comply with
any Applicable Laws. As to any jurisdiction that expressly imposes the requirement that an Option or SAR that may be settled in shares
of Common Stock will not be exercisable until the shares of Common Stock subject to such Option or SAR are registered under the securities
laws thereof or are exempt from such registration, the exercise of such Option or SAR under circumstances in which the laws of such jurisdiction
apply will be deemed conditioned upon the effectiveness of such registration or the availability of such an exemption.
16.2 Rule 16b-3.
During any time when the
Company has a class of equity security registered under Section 12 of the Exchange Act, it is the intention of the Company that
Awards pursuant to the Plan and the exercise of Options and SARs granted hereunder that would otherwise be subject to Section 16(b) of
the Exchange Act will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision
of the Plan or action by the Committee does not comply with the requirements of such Rule 16b-3, such provision or action will be
deemed inoperative with respect to such Awards to the extent permitted by Applicable Laws and deemed advisable by the Committee, and
will not affect the validity of the Plan. In the event that such Rule 16b-3 is revised or replaced, the Board may exercise its discretion
to modify the Plan in any respect necessary or advisable in its judgment to satisfy the requirements of, or to permit the Company to
avail itself of the benefits of, the revised exemption or its replacement.
| 17. | EFFECT
OF CHANGES IN CAPITALIZATION |
17.1 Changes
in Common Stock.
If the number of outstanding
shares of Common Stock is increased or decreased or the shares of Common Stock are changed into or exchanged for a different number of
shares or kind of equity shares or other securities of the Company on account of any recapitalization, reclassification, stock split,
reverse stock split, spin-off, combination of stock, exchange of shares, stock dividend or other distribution payable in equity shares,
or other increase or decrease in shares of Common Stock effected without receipt of consideration by the Company occurring after the
Effective Date, the number and kinds of equity shares for which grants of Options and other Awards may be made under the Plan will be
adjusted proportionately and accordingly by the Committee. In addition, the number and kind of equity shares for which Awards are outstanding
will be adjusted proportionately and accordingly by the Committee so that the proportionate interest of the Grantee therein immediately
following such event will, to the extent practicable, be the same as immediately before such event. Any such adjustment in outstanding
Options or SARs will not change the aggregate Option Price or SAR Price payable with respect to shares that are subject to the unexercised
portion of such outstanding Options or SARs, as applicable, but will include a corresponding proportionate adjustment in the per share
Option Price or SAR Price, as the case may be. The conversion of any convertible securities of the Company will not be treated as an
increase in shares effected without receipt of consideration. Notwithstanding the foregoing, in the event of any distribution to the
Company’s stockholders of securities of any other entity or other assets (including an extraordinary dividend, but excluding a
non-extraordinary dividend, declared and paid by the Company) without receipt of consideration by the Company, the Board or the Committee
constituted pursuant to Section 3.1(b) will, in such manner as the Board or the Committee deems appropriate, adjust
(a) the number and kind of shares of Common Stock subject to outstanding Awards and/or (b) the aggregate and per share Option
Price of outstanding Options and the aggregate and per share SAR Price of outstanding SARs as required to reflect such distribution.
17.2 Reorganization
in Which the Company Is the Surviving Entity That Does not Constitute a Change in Control.
Subject to Section 17.3,
if the Company will be the surviving entity in any reorganization, merger or consolidation of the Company with one or more other entities
that does not constitute a Change in Control, any Option or SAR theretofore granted pursuant to the Plan will pertain to and apply to
the securities to which a holder of the number of shares of Common Stock subject to such Option or SAR would have been entitled immediately
following such reorganization, merger or consolidation, with a corresponding proportionate adjustment of the per share Option Price or
SAR Price so that the aggregate Option Price or SAR Price thereafter will be the same as the aggregate Option Price or SAR Price of the
shares of Common Stock remaining subject to the Option or SAR as in effect immediately prior to such reorganization, merger, or consolidation.
Subject to any contrary language in an Award Agreement or in another agreement with the Grantee, or otherwise set forth in writing, any
restrictions applicable to such Award will apply as well to any replacement shares received by the Grantee as a result of such reorganization,
merger or consolidation. In the event of any reorganization, merger or consolidation of the Company referred to in this Section 17.2,
Performance-Based Awards will be adjusted (including any adjustment to the Performance Measures applicable to such Awards deemed appropriate
by the Committee) so as to apply to the securities that a holder of the number of shares of Common Stock subject to the Performance-Based
Awards would have been entitled to receive immediately following such reorganization, merger or consolidation.
17.3 Change
in Control in which Awards are not Assumed.
Except as otherwise provided
in the applicable Award Agreement or in another agreement with the Grantee, or as otherwise set forth in writing, upon the occurrence
of a Change in Control in which outstanding Options, SARs, Restricted Stock, Restricted Stock Units, Deferred Stock Units, Dividend Equivalent
Rights or Other Equity-Based Awards are not being assumed or continued, the following provisions will apply to such Award, to the extent
not assumed or continued:
(a) in
each case with the exception of Performance-Based Awards, all outstanding shares of Restricted Stock will be deemed to have vested, all
Restricted Stock Units and Deferred Stock Units will be deemed to have vested and the shares of Common Stock subject thereto will be
delivered, and all Dividend Equivalent Rights will be deemed to have vested and the shares of Common Stock subject thereto will be delivered,
immediately prior to the occurrence of such Change in Control, and either of the following two actions will be taken:
(i) 15 days
prior to the scheduled consummation of such Change in Control, all Options and SARs outstanding hereunder will vest and become immediately
exercisable and will remain exercisable for a period of 15 days, which exercise will be effective upon such consummation; or
(ii) the
Committee may elect, in its sole discretion, to cancel any outstanding Awards of Options, SARs, Restricted Stock, Restricted Stock Units,
Deferred Stock Units and/or Dividend Equivalent Rights and pay or deliver, or cause to be paid or delivered, to the holder thereof an
amount in cash or securities having a value (as determined by the Committee acting in good faith), in the case of Restricted Stock, Restricted
Stock Units, Deferred Stock Units and Dividend Equivalent Rights (for shares of Common Stock subject thereto), equal to the formula or
fixed price per share paid to holders of shares of Common Stock pursuant to such Change in Control and, in the case of Options or SARs,
equal to the product of the number of shares of Common Stock subject to such Options or SARs (the “Award Shares”)
multiplied by the amount, if any, by which (x) the formula or fixed price per share paid to holders of shares of Common Stock pursuant
to such transaction exceeds (y) the Option Price or SAR Price applicable to such Award Shares.
(b) Performance-Based
Awards shall become earned and vested based on the greater of (i) the target level of performance or (ii) actual performance
measured as of a date reasonably proximal to the date of consummation of the Change in Control, as determined by the Committee, in its
sole discretion. For purposes of the preceding sentence, if, based on the discretion of the Committee, actual performance is not determinable,
the Awards will be treated as though the target level of performance has been achieved. After application of this Section 17.3(b),
if any Awards arise from application of this Section 17, such Awards will be settled under the applicable provision of Section 17.3(a).
(c) Other
Equity-Based Awards will be governed by the terms of the applicable Award Agreement.
With respect to the Company’s
establishment of an exercise window, (a) any exercise of an Option or SAR during the 15-day period referred to above will be conditioned
upon the consummation of the applicable Change in Control and will be effective only immediately before the consummation thereof, and
(b) upon consummation of any Change in Control, the Plan and all outstanding but unexercised Options and SARs will terminate. The
Committee will send notice of an event that will result in such a termination to all natural persons and entities who hold Options and
SARs not later than the time at which the Company gives notice thereof to its stockholders.
17.4 Change
in Control in which Awards are Assumed.
Except as otherwise provided
in the applicable Award Agreement or in another agreement with the Grantee, or as otherwise set forth in writing, upon the occurrence
of a Change in Control in which outstanding Options, SARs, Restricted Stock, Restricted Stock Units, Deferred Stock Units, Dividend Equivalent
Rights or Other Equity-Based Awards are being assumed or continued, the following provisions will apply to such Award, to the extent
assumed or continued:
The Plan and the Options,
SARs, Restricted Stock, Restricted Stock Units, Deferred Stock Units, Dividend Equivalent Rights and Other Equity-Based Awards granted
under the Plan will continue in the manner and under the terms so provided in the event of any Change in Control to the extent that provision
is made in writing in connection with such Change in Control for the assumption or continuation of such Options, SARs, Restricted Stock,
Restricted Stock Units, Deferred Stock Units, Dividend Equivalent Rights and Other Equity-Based Awards, or for the substitution for such
Options, SARs, Restricted Stock, Restricted Stock Units, Deferred Stock Units, Dividend Equivalent Rights and Other Equity-Based Awards
of new common share options, share appreciation rights, restricted share, common restricted share units, common deferred share units,
dividend equivalent rights and other equity-based awards relating to the equity of a successor entity, or a parent or subsidiary thereof,
with appropriate adjustments as to the number of shares (disregarding any consideration that is not common shares) and option and share
appreciation rights exercise prices. Without limiting the generality of the foregoing, all incomplete Performance Periods in respect
of each Performance-Based Award shall end on the date of the Change in Control and the performance goals applicable to such Award shall
be deemed satisfied at either (a) the target level of performance or (b) the actual level of performance measured as of a date
reasonably proximal to the date of consummation of the Change in Control, as determined by the Committee, in its sole discretion, in
each case, whichever approach results in the greater number of Performance-Based Awards becoming earned. For purposes of the preceding
sentence, if, based on the discretion of the Committee, actual performance is not determinable, the performance goals applicable to such
Award shall be deemed satisfied at the target level of performance. Each such Performance-Based Award shall thereafter become a time-based
Award and shall otherwise vest in accordance with the applicable Award Agreement. In the event an Award is assumed, continued or substituted
upon the consummation of any Change in Control and the employment of such Grantee with the Company or an Affiliate is terminated without
Cause within 12 months following the consummation of such Change in Control, such Award will be fully vested and may be exercised in
full, to the extent applicable, beginning on the date of such termination and for the one-year period immediately following such termination
or for such longer period as the Committee will determine.
17.5 Adjustments
Adjustments under this Section 17
related to shares of Common Stock or other securities of the Company will be made by the Committee, whose determination in that respect
will be final, binding and conclusive. No fractional shares or other securities will be issued pursuant to any such adjustment, and any
fractions resulting from any such adjustment will be eliminated in each case by rounding downward to the nearest whole share. The Committee
may provide in the applicable Award Agreement at the time of grant, in another agreement with the Grantee, or otherwise in writing at
any time thereafter with the consent of the Grantee, for different provisions to apply to an Award in place of those provided in Sections
17.1, 17.2, 17.3 and 17.4. This Section 17 will not limit the Committee’s ability to provide for alternative
treatment of Awards outstanding under the Plan in the event of a change in control event involving the Company that is not a Change in
Control.
17.6 No
Limitations on Company.
The making of Awards pursuant
to the Plan will not affect or limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations,
or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part
of its business or assets (including all or any part of the business or assets of any Subsidiary or other Affiliate) or engage in any
other transaction or activity.
18.1 Disclaimer
of Rights.
No provision in the Plan
or in any Award or Award Agreement will be construed to confer upon any individual the right to remain in the employ or Service of the
Company or an Affiliate, or to interfere in any way with any contractual or other right or authority of the Company an Affiliate either
to increase or decrease the compensation or other payments to any natural person or entity at any time, or to terminate any employment
or other relationship between any natural person or entity and the Company or an Affiliate. In addition, notwithstanding anything contained
in the Plan to the contrary, unless otherwise stated in the applicable Award Agreement, in another agreement with the Grantee, or otherwise
in writing, no Award granted under the Plan will be affected by any change of duties or position of the Grantee thereof, so long as such
Grantee continues to provide Service. The obligation of the Company to pay any benefits pursuant to the Plan will be interpreted as a
contractual obligation to pay only those amounts provided herein, in the manner and under the conditions prescribed herein. The Plan
and Awards will in no way be interpreted to require the Company to transfer any amounts to a third-party trustee or otherwise hold any
amounts in trust or escrow for payment to any Grantee or beneficiary under the terms of the Plan.
18.2 Nonexclusivity
of the Plan.
Neither the adoption of
the Plan nor the submission of the Plan to the stockholders of the Company for approval will be construed as creating any limitations
upon the right and authority of the Board to adopt such other incentive compensation arrangements (which arrangements may be applicable
either generally to a class or classes of individuals or specifically to a particular individual or particular individuals) as the Board
in its discretion determines desirable.
18.3 Withholding
Taxes.
The Company or an Affiliate,
as the case may be, will have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state, or local taxes
of any kind required by law to be withheld with respect to the vesting of or other lapse of restrictions applicable to an Award or upon
the issuance of any shares of Common Stock upon the exercise of an Option or pursuant to any other Award. At the time of such vesting,
lapse, or exercise, the Grantee will pay in cash to the Company or an Affiliate, as the case may be, any amount that the Company or such
Affiliate may reasonably determine to be necessary to satisfy such withholding obligation; provided that if there is a same-day
sale of shares of Common Stock subject to an Award, the Grantee will pay such withholding obligation on the day on which such same-day
sale is completed. Subject to the prior approval of the Company or an Affiliate, which may be withheld by the Company or such Affiliate,
as the case may be, in its sole discretion, the Grantee may elect to satisfy such withholding obligation, in whole or in part, (a) by
causing the Company or an Affiliate to withhold shares of Common Stock otherwise issuable to the Grantee or (b) by delivering to
the Company or an Affiliate shares of Common Stock already owned by the Grantee. The shares of Common Stock so withheld or delivered
will have an aggregate Fair Market Value equal to such withholding obligation. The Fair Market Value of the shares of Common Stock used
to satisfy such withholding obligation will be determined by the Company or such Affiliate as of the date on which the amount of tax
to be withheld is to be determined. A Grantee who has made an election pursuant to this Section 18.3 may satisfy such Grantee’s
withholding obligation only with shares of Common Stock that are not subject to any repurchase, forfeiture, unfulfilled vesting, or other
similar requirements. The maximum number of shares of Common Stock that may be withheld from any Award to satisfy any federal, state
or local tax withholding requirements upon the exercise, vesting, or lapse of restrictions applicable to any Award or payment of shares
of Common Stock pursuant to such Award, as applicable, may not exceed such number of shares of Common Stock having a Fair Market Value
equal to the maximum statutory amount required by the Company or the applicable Affiliate to be withheld and paid to any such federal,
state or local taxing authority with respect to such exercise, vesting, lapse of restrictions, or payment of shares of Common Stock.
Notwithstanding Section 2.21 or this Section 18.3, for purposes of determining taxable income and the amount
of the related tax withholding obligation pursuant to this Section 18.3, for any shares of Common Stock subject to an Award
that are sold by or on behalf of a Grantee on the same date on which such shares may first be sold pursuant to the terms of the related
Award Agreement, the Fair Market Value of such shares will be the sale price of such shares on such date (or if sales of such shares
are effectuated at more than one sale price, the weighted average sale price of such shares on such date), so long as such Grantee has
provided the Company, or its designee or agent, with advance written notice of such sale.
18.4 Captions.
The use of captions in the
Plan or any Award Agreement is for convenience of reference only and will not affect the meaning of any provision of the Plan or such
Award Agreement.
18.5 Construction.
Unless the context otherwise
requires, all references in the Plan to “including” will mean “including without limitation.”
18.6 Other
Provisions.
Each Award granted under
the Plan may contain such other terms and conditions not inconsistent with the Plan as may be determined by the Committee, in its sole
discretion.
18.7 Number
and Gender.
With respect to words used
in the Plan, the singular form will include the plural form and the masculine gender will include the feminine gender, as the context
requires.
18.8 Severability.
If any provision of the
Plan or any Award Agreement will be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining
provisions hereof and thereof will be severable and enforceable in accordance with their terms, and all provisions will remain enforceable
in any other jurisdiction.
18.9 Governing
Law.
The validity and construction
of the Plan and the instruments evidencing the Awards hereunder will be governed by, and construed and interpreted in accordance with,
the laws of the State of Delaware, other than any conflicts or choice of law rule or principle that might otherwise refer construction
or interpretation of the Plan and the instruments evidencing the Awards granted hereunder to the substantive laws of any other jurisdiction.
18.10 Code
Section 409A.
The Plan is intended to
comply with Code Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan will be
interpreted and administered to be in compliance with Code Section 409A. Any payments described in the Plan that are due within
the “short-term deferral period” as defined in Code Section 409A will not be treated as deferred compensation unless
Applicable Laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated
taxation and tax penalties under Code Section 409A, amounts that would otherwise be payable and benefits that would otherwise be
provided pursuant to the Plan during the six-month period immediately following the Grantee’s termination of “separation
from service” (as defined for purposes of Code Section 409A) will instead be paid on the first payroll date after the six-month
anniversary of the Grantee’s separation from service (or the Grantee’s death, if earlier).
Furthermore, notwithstanding
anything to the contrary in the Plan, in the case of an Award that is characterized as deferred compensation under Code Section 409A,
and pursuant to which settlement and delivery of the cash or shares of Common Stock subject to the Award is triggered based on a Change
in Control, in no event will a Change in Control be deemed to have occurred for purposes of such settlement and delivery of cash or shares
of Common Stock if the transaction is not also a “change in the ownership or effective control of” the Company or “a
change in the ownership of a substantial portion of the assets of” the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without
regard to any alternative definition thereunder). If an Award characterized as deferred compensation under Code Section 409A is
not settled and delivered on account of the provision of the preceding sentence, the settlement and delivery will occur on the next succeeding
settlement and delivery triggering event that is a permissible triggering event under Code Section 409A. No provision of this paragraph
will in any way affect the determination of a Change in Control for purposes of vesting in an Award that is characterized as deferred
compensation under Code Section 409A.
Notwithstanding the foregoing,
neither the Company, any Affiliate nor the Committee will have any obligation to take any action to prevent the assessment of any excise
tax or penalty on any Grantee under Section 409A of the Code and neither the Company, any Affiliate nor the Committee will have
any liability to any Grantee for such tax or penalty.
* * *
To record adoption of the
Plan by the Board as of March 26, 2024, and approval by the stockholders of the Company on May 22, 2024, the Company has caused
its authorized officer to execute the Plan.
| MARINUS PHARMACEUTICALS, INC. |
| |
| /s/Steven Pfanstiel |
| By: | Steven Pfanstiel |
| Title: | Chief Operating Officer, Chief Financial Officer and Treasurer |
v3.24.1.1.u2
Cover
|
May 22, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
May 22, 2024
|
Entity File Number |
001-36576
|
Entity Registrant Name |
Marinus
Pharmaceuticals, Inc.
|
Entity Central Index Key |
0001267813
|
Entity Tax Identification Number |
20-0198082
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
5 Radnor Corporate Center
|
Entity Address, Address Line Two |
Suite 500
|
Entity Address, Address Line Three |
100
Matsonford Rd
|
Entity Address, City or Town |
Radnor
|
Entity Address, State or Province |
PA
|
Entity Address, Postal Zip Code |
19087
|
City Area Code |
484
|
Local Phone Number |
801-4670
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, par value $0.001
|
Trading Symbol |
MRNS
|
Security Exchange Name |
NASDAQ
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 3 such as an Office Park
+ References
+ Details
Name: |
dei_EntityAddressAddressLine3 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Aug 2023 to Aug 2024